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Abundancy of polymorphic CGG 
repeats in the human genome 
suggest a broad involvement 
in neurological disease
Dale J. Annear1, Geert Vandeweyer1, Ellen Elinck1, Alba Sanchis‑Juan2,3, Courtney E. French4, 
Lucy Raymond2,5 & R. Frank Kooy1*
Expanded CGG‑repeats have been linked to neurodevelopmental and neurodegenerative disorders, 
including the fragile X syndrome and fragile X‑associated tremor/ataxia syndrome (FXTAS). We 
hypothesized that as of yet uncharacterised CGG‑repeat expansions within the genome contribute 
to human disease. To catalogue the CGG‑repeats, 544 human whole genomes were analyzed. In 
total, 6101 unique CGG‑repeats were detected of which more than 93% were highly variable in repeat 
length. Repeats with a median size of 12 repeat units or more were always polymorphic but shorter 
repeats were often polymorphic, suggesting a potential intergenerational instability of the CGG region 
even for repeats units with a median length of four or less. 410 of the CGG repeats were associated 
with known neurodevelopmental disease genes or with strong candidate genes. Based on their 
frequency and genomic location, CGG repeats may thus be a currently overlooked cause of human 
disease.
Repetitive DNA tracts make up a significant portion of the human genome. Short tandem repeats (STRs) are 
defined as DNA motifs typically ranging from 1 to 6, usually repeated between 5 to 200 units in tandem. In 
total, these repeats account for 3% of the total human  genome1,2. Presently, over 30 genetic disorders have been 
identified resulting from STR  expansions3. CGG repeats form a specific STR subcategory, associated with human 
disease, through two distinct mutational mechanisms. The principle examples of CGG repeat expansions dis-
orders are the fragile X syndrome and the fragile X associated tremor/ataxia syndrome (FXTAS)4,5. The fragile 
X syndrome is a frequent syndromic form of intellectual disability (ID) and autism, caused by an expansion of 
the CGG-repeat in the 5-’UTR of the fragile X mental retardation 1 (FMR1) gene, into the full mutation range 
(> 200 repeats). The expansion triggers an epigenetic mechanism of DNA methylation and additional chromatin 
remodelling culminating in the transcriptional silencing of FMR1. Interestingly, when the repeat is present in 
the “premutation range” of 55 to 200 units, carriers do not develop fragile X syndrome but are at risk for the 
late-onset neurodegenerative disorder, FXTAS. Patients present with cerebellar gait ataxia intentional tremor and 
other neurological symptoms. Brain atrophy, white matter disease, and hyperintensities of the middle cerebellar 
peduncles can also be present. The disease mechanism of FXTAS is unclear but likely to involve sequestering of 
RNA’s to the elongated CGG repeat and repeat-associated non-AUG (RAN) translation. Interestingly, several 
lines of evidence suggest that FXTAS is a consequence of the CGG-repeat elongation per se, independent of its 
location within the FMR1 gene. Furthermore, in females, the FMR1 premutation range repeat is associated with 
fragile X-associated primary ovarian insufficiency (FXPOI), categorized by ovarian insufficiency and hormonal 
 irregularities6. Many FXPOI patients report higher indices of thyroid-related issues, depression and  anxiety6.
Historically, CGG-repeat expansions present as characteristic breaks or gaps in karyotypes obtained from 
blood cells under folate-deprived  conditions7. Apart from FRAXA, associated with the fragile X syndrome, 21 
additional so-called fragile sites of this rare, folate-sensitive type have been  described8–10. In the 1970s, karyo-
typing under folate-deprived conditions was a routine diagnostic procedure for patients with ID. Some studies 
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reported an elevated prevalence of fragile sites in patient populations, with a cumulative frequency of more 
than 1%, which was not observed in control  populations11,12. In the decades to follow, 10 of these fragile sites 
have been cloned as an expanded CGG repeat and more than half have been at least tentatively associated with 
neurodevelopmental disease. For instance, a CGG repeat located close to the repeat expanded in the fragile 
X syndrome was found to be associated with a non-syndromic form of ID, shortly after the discovery of the 
fragile X  syndrome13,14. In addition, FRA2A has been associated with developmental delay/ID15, FRA7A with 
autism, FRA11B with Jacobsen  syndrome16, FRA12A with  ID17 and, most recently, FRA16A with Baratela-Scott 
 syndrome18 (see Table 1).
We hypothesized that CGG-repeat expansions are more prevalent in the human genome than currently 
appreciated and that these expansions might have a role in neurodevelopmental disease. Using recently devel-
oped genome-wide STR genotyping tools, we catalogued thousands of CGG-repeats that display characteristics 
similar to known disease-causing CGG-repeats. Moreover, hundreds of these are associated with known ID/
autism genes. Our findings thus raise further questions about the biological role of CGG-repeats and what risk 
they may pose concerning genetic disease.
Results
Genome‑wide identification of CGG short tandem repeats. Using the Tandem Repeats Finder algo-
rithm to extract repetitive sequences from the GRCh37/hg19 reference genome, we retained a total of 6110 
CGG-repeats with a length of 4 or more units. The repeats are unequally distributed across the genome (Figs. 1 
and 2), with densities ranging from 0.52 to 5.7 repeats per Mb, for chromosomes 14 and 22 respectively. Interest-
ingly, the Y chromosome is virtually devoid of CGG-repeats.
In total, of the 6110 repeat loci in our experimental data, 8 had to be disregarded due to poor coverage while 
one repeat locus was disregarded due to the presence of only partial flanking reads. The remaining 6101 repeats 
were within or in proximity to 4370 different known genes. Of those, 3335 genes contained at least one intra-
genic CGG-repeat, although many were associated with multiple CGG repeats within or immediately (within 
1000 bp) upstream or downstream of the gene. 824 genes contained at least one CGG-repeat within the adjacent 
intergenic regions. Of these, 211 genes contained both an intragenic CGG-repeat and a CGG-repeat in the sur-
rounding intergenic regions. The majority of CGG-repeats fell within the 5′-UTR gene regions (n = 1836/6101), 
exons (n = 1529/6101), or immediately upstream of genes (n = 849/6101) (Fig. 3). Interestingly, there was an 
almost complete lack of CGG-repeats within the 3′-UTR (n = 34) and immediate downstream (n = 11) regions.
Genotyping accuracy. Several STR genotypers exist to evaluate repeat lengths in short-read whole-genome 
sequencing  data19. To validate the output of the genotypers, we compared the performance of  GangSTR20 and 
 ExpansionHunter21 on a cohort of 100 whole genomes (WGS) samples in detail. There was a 91.22% consistency 
between the two program suites: 34.92% (n = 211,262/605,074) of the called repeat alleles were genotyped iden-
tically by ExpansionHunter and GangSTR, while 56.30% (n = 340,666/605,074) of the calls differed by a single 
repeat unit, which was attributed to different handling of incomplete trailing repeat units. The primary reason for 
the 8.78% genotype discrepancies between both algorithms was related to the inability of GangSTR to account for 
repeat interruptions, leading to larger repeat size estimations by ExpansionHunter in 6.82% (n = 41,274/605,074) 
of calls. In 0.61% (n = 3678/605,074) of calls, GangSTR predicted larger repeat lengths, by compounding reads 
together and apparently overestimating the length of the repeat. Finally, in 1.35% (n = 8194/605,074) of calls, 
GangSTR failed to genotype repeats while ExpansionHunter did provide a genotype. Experimental validation 
of some of the repeats in ABCD3, ACVR2A, LHX5-AS1, SHANK2, RASGEF1C, and TMEM268 in a subset of 
Table 1.  Overview of the confirmed rare folate-sensitive fragile sites and their associated CGG-repeats. *In the 
case of multiple repeats, the repeat indicated as causative of the associated folate sensitive fragile site.
Fragile site Gene Region
Cohort 
polymorphism Reference units Median units Minimum units Maximum units
FRA2A AFF3
Intronic
95%* 12 16 1 64
99% 4 15 1 43
5′-UTR 12% 8 9 4 47
FRA7A ZNF713
* 5′-UTR 81% 12 13 5 53
Intronic 92% 21 18 1 53
FRA10A FRA10AC1 5′-UTR 72% 8 9 5 115
FRA11A C11orf80 Exonic 48% 8 10 4 62
FRA11B CBL 5′-UTR 88% 11 13 6 52
FRA12A DIP2B 5′-UTR 97% 12 14 8 120
FRA16A XYLT1 Upstream 95% 4 43 1 83
FRAXA FMR1 5′-UTR 100% 20 28 4 52
FRAXE AFF2
5′-UTR 77%* 28 30 1 59
34% 4 5 5 55
FRAXF TMEM185A 5′-UTR 61% 10 12 3 55
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Figure 1.  Ideogram of the distribution of all detected CGG short tandem repeats throughout the human 
genome. Red bars above the chromosome represent the position and size of polymorphic CGG STRs (n = 5683) 
while the blue bars below represent the stable CGG STRs (n = 418). Median repeat length is indicated by the 
bar length and length range is indicated on the Y-axis accompanying each chromosome. Green regions on the 
chromosomes indicate the cytogenic positions where cytogenetically visible folate-sensitive fragile sites have 
been previously recorded, with the green text indicating the identity of each fragile site. Green markers on repeat 
bars indicate CGG STRs which have been previously identified as the causative repeats of the associated fragile 
 site7. The y-axis bar length equals 32 on all chromosomes.
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the individuals in our cohort showed that repeat lengths predicted by ExpansionHunter were identical with the 
repeat lengths measured through PCR amplification and Sanger sequencing (Supplementary Fig. 1). Based on 
these observations, combined with the ability of ExpansionHunter to estimate repeat lengths beyond the short-
read lengths and handle repeat interruptions, we selected this algorithm for our further analyses. Furthermore, 
as most other STR genotypers also require a repeat coordinate file (based on STR locations in the reference 
genome) at the initialization of the algorithm, it seems unlikely to us that use of similar STR genotypers over 
ExpansionHunter would yield a greater detection of CGG-repeats.
Figure 2.  Distribution and density of CGG short tandem repeats per chromosome. Percentage total of CGG 
STRs per chromosome are represented by the blue bars. Repeat density per chromosome (repeats per Mbp) for 
polymorphic (n = 5683) and total (n = 6101) CGG STRs are represented by red and orange lines respectively.
Figure 3.  Occurrence of stable and polymorphic CGG short tandem repeats throughout the different genetic 
regions. Percentage total of uniform and polymorphic CGG STRs by genetic region. Upstream (< 1 kb from 
start of gene) (n = 849), 5′-UTR (n = 1836), Exonic (n = 1529), Intronic (n = 925), 3′-UTR (n = 34), Downstream 
(< 1 kb from end of gene) (n = 11), Intergenic (> 1 kb from gene) (n = 625), and ncRNA (n = 292).
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Characterization of allelic polymorphism of the CGG‑repeats. PCR-free WGS data was obtained 
from a control cohort of 544 unrelated adult individuals from the Next Generation Children project (NGC)22. 
Out of the 6110 CGG-repeat sites investigated, nine loci were excluded as none of the WGS samples included 
spanning or in-repeats reads for those loci. Overall, approximately 99.8% of alleles were genotyped at the remain-
ing 6101 sites. Strikingly, across the cohort, 93.1% (n = 5683/6101) of the CGG-repeat loci displayed a least some 
degree of variability, with only 6.9% (n = 418/6101) of the CGG-repeat loci showing uniform size. We noticed 
that in many cases the observed median repeat lengths were discordant with the repeat length provided by the 
GRCh37/hg19 reference genome. Therefore, we substituted the repeat length annotated in the reference genome 
with the total population median repeat length observed in our study cohort. This value, referred to as the 
median repeat length for the remainder of the study, ranged from 2 to 56 units in our cohort. Although we did 
not target repeats with a reference length below four units, several loci showed an experimental median popula-
tion repeat length below our original detection threshold. CGG-repeat loci variation can be observed in Fig. 4, 
and the full repeat catalogue with observed population characteristics is available in supplementary Table 1. 
In general, we observed highly variable CGG-repeat characteristics amongst the individuals of our cohort. On 
average 18.2% (range 13%-34%) of all CGG-repeats in each individual were polymorphic, with the largest repeat 
observed ranging from 54 to 120 units.
Next, Fig. 4 summarizes to what degree (prevalence) and extent (size) the 5683 polymorphic CGG-repeat 
loci tend to deviate from the median population repeat length. As expected, repeats exhibiting a lower median 
repeat length tended to cluster near their expected length, while larger repeats showed a broader variability range. 
Nevertheless, even loci with a median repeat length of 1–3 units, exhibited significant repeat size polymorphisms. 
Similarly, the largest allele observed at any locus seemed almost independent of its median repeat length. For 
instance, the largest allele observed in our cohort consisted of 120 repeat units and was detected at a locus with 
a median repeat length of 14 units. In contrast, the smallest observed allele for many loci was just a single repeat 
unit in size. This holds mainly at smaller loci but was also detected in repeats with a median repeat size of up 
to 43 repeat units. Overall, our results indicate a positive correlation between the median repeat length and the 
degree of polymorphism across samples (Supplementary Fig. 2). At a median of 4 CGG-units, approximately 
85% of all loci displayed a length polymorphism in at least a single individual, while the remaining 15% were 
non-polymorphic throughout the full cohort. Conversely, approximately 96% of repeats with a median repeat 
length of 8 units were polymorphic and all repeats with a median repeat length over 12 units were polymorphic.
Characteristics of the known fragile site associated CGG short tandem repeats. All ten repeats 
previously cloned based on their association with chromosome fragile sites were detected within our analysis 
(Table 1). Out of the known disease-associated repeats, the FRA16A/XYLT1 gene displayed the largest median 
repeat length in our cohort, with 43 repeat units, while the other fragile site-associated repeats displayed a 
Figure 4.  Deviation in length of polymorphic repeats from the median locus repeat length. Here, all observed 
repeat lengths of all polymorphic repeat alleles were plotted against the respective locus median repeat length. 
The X-axis is not continuous as at the higher end of median repeat lengths not all sizes were represented. It can 
be noted that for repeat loci with lower median repeat length, most observed repeat lengths clustered around the 
median repeat length. However, many of these observed repeat lengths at this range still differed considerably 
from the median repeat length. In general, observed repeat length variance appeared to increase as the median 
repeat length increased (Supplementary Table 2).
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median repeat length in the range of 5 to 30 CGG-units (Table 1). In terms of the largest fragile site-associated 
repeat detected among the cohort, one individual displayed a FRA12A/DIP2B CGG-repeat length of 120 repeat 
units. Another individual displayed a repeat of 115 repeat units in the 5′-UTR of the FRA10AC1 gene (Table 1).
Interestingly, in several of the genes associated with a fragile site, we observed multiple CGG-repeats. 
FRA2A/AFF3 was observed as containing three separate CGG-repeats, while FRA7A/ZNF713 and FRAXE/AFF2 
both contained two repeats. Although one of the repeats in the AFF3 gene displayed a relatively low polymor-
phism rate and a short median repeat length, all three repeats displayed the ability to expand by a considerable 
length. This was also observed in the AFF2 gene, where the second repeat, with a polymorphism rate of 34% and 
a median repeat length of 5, was seen to expand as high as 55 repeat units. Illustrating the functional variability 
of repeats, it is the intronic repeat in AFF3 (Median Units: 16) which, has been credited as the causal repeat 
behind FRA2A, while in ZNF713 it is the 5′-UTR repeat which is reported as the cause of  FRA7A15,23. In addi-
tion, the repeat with the largest median repeat length was 56 CGG-units long and located in the intergenic space 
between the genes RGPD5 and RGPD6 in the 2q13 cytoband, where the 2B folate-sensitive fragile site is located.
In analogy with the paralogous genes AFF2 and AFF3 that are both preceded by a CGG repeat, other gene 
families appeared to be highly associated with CGG-STRs. An example is the family of forkhead box (FOX) 
genes. The FOXP1 gene is a gene commonly linked to ID, and we detected two CGG-STRs within this gene. No 
less than 75 CGG repeats in total were observed associated with its paralogues. Several paralogues contained 
multiple repeats, such as FOXD4L5 (9), FOXC1 (6), FOXD1 (6), FOXD4L4 (4), and FOXG1 (3), including several 
large and highly unstable repeats.
Functional annotation of CGG‑repeat‑associated genes. To investigate a possible correlation with 
neurodevelopmental disease, we investigated the characteristics of genes associated with CGG repeats apart 
from those associated with known fragile sites. We compared the 4370 CGG-linked genes with a list of 1295 ID 
genes used in our centre for routine screening for ID and related neurodevelopmental disease. We highlighted 
410 genes associated with neurodevelopmental disease. We observed a significant enrichment of known ID 
genes within the CGG-associated genes (chi-square; p < 2.2e-16; Table 2), with at least 26% of all established ID 
genes containing 1 or more CGG repeats. ID genes were classified as either repeat-associated or non-repeat-
associated. Therefore, the number of repeats associated with each gene did not affect our analyses.
Interestingly, 57% of genes containing a polymorphic CGG-repeat (n = 2017/3546), displayed a low haplo-
insufficiency index of less than 40% and 46% (n = 1621/3546) of these genes displayed a pLi score greater than 
0.75. Both these scores indicate a likely intolerance to a reduction in expression following silencing of one of the 
present alleles, making these genes potential candidates for further investigations into CGG-expansion induced 
silencing and functional disruption.
A more general functional evaluation of CGG-linked genes was conducted using the PANTHER Classifica-
tion System. A total of 3864/4370 CGG-associated genes were mapped to the PANTHER database. Based on 
these genes, enrichment analysis was performed on 4255 Gene Ontology hits for biological processes, 3110 for 
molecular function, 2686 for cellular components, 2446 for protein class, and 1944 for pathway involvement. In 
all categories, we observed a diverse set of associated roles (Supplementary Fig. 3). Of interest was the relatively 
high occurrence of items related to transcription regulation, including transcription factors (protein class; 16.4%), 
and transcription regulation (molecular function; 12.8%). Amongst the 114 different biological roles identified, 
most pathways represented less than 1% of the genes. In contrast, the Gonadotropin-releasing hormone recep-
tor pathway and the Wnt signalling pathway were both associated with 5.5% of the genes. The CCKR signalling 
map, Angiogenesis, and Integrin signalling pathway made up 3.8%, 3.1%, and 3% of the results respectively.
Discussion
We applied Tandem Repeats Finder to build a catalogue of CGG-STRs in the human genome. In total, we con-
firmed 6101 unique loci, including all 10 CGG repeats associated with known fragile sites. We characterized this 
specific class of STR using ExpansionHunter in a control cohort of 544 unrelated individuals. The overall allele 
size heterogeneity of the CGG repeats is astonishing. We found that 93.1% of the loci show length polymor-
phisms. Median repeat lengths ranged from 2–56 repeat units, with individual genotypes ranging from 1 to 120 
repeat units. Even repeat loci with a median repeat length as low as 4 repeat units showed alleles of over 50 repeat 
units in some individuals, although overall in our cohort analysis the majority of larger alleles were related to loci 
with higher median repeat sizes. Repeats induce unusual DNA structures that can result in strand slippage during 
both meiotic and mitotic DNA replication, repair and  recombination24. It is therefore likely that the observed 
allelic heterogeneity is a result of replication errors in germline cells or their precursors in previous generations.
A feature discriminating CGG-repeats from other STRs is their predominant location with respect to genes. 
While STR in general are relatively equally distributed over the genome over 50% of CGG-repeats were detected 
within exonic and 5′-UTR regions, in line with earlier observations that demonstrated that CG-rich repeats are 
overrepresented in the exonic  regions25,26. This is in line with previous studies reporting predominance of CGG-
repeats in promoter regions in humans, and even in  yeast27,28. While it has been reported that the Y chromosome 
displays STR densities comparable with the other chromosomes, both this study and Subramanian and colleagues 
indicate this is not the case for CGG STRs as the Y chromosome was virtually depleted of CGG-repeats in our 
 study25. It has been reported that the length of individual STR-alleles may play a role in the expression of various 
complex  traits29,30 and as CGG-repeats are preferentially located at or near promotor sites, it can be speculated 
that the variability in length we detected potentially plays a role in gene-expression regulation. Another hint 
of the functional relevance is the conservation of CGG repeats across gene families, such as the AFF and FOX 
families of genes. At this stage, it is not known whether these CGG-repeats were present in the single common 
ancestral gene and were retained in some paralogues but lost in others or whether the repeat arose independently 
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after the evolution of the paralogous genes. Several studies have explored cross-species differences and impacts 
of STRs. While many repeat loci are conserved across mammalians their characteristics differ depending on the 
 species31–33. Orthologous repeat loci often differ in polymorphisms, repeat length, and repeat interruptions based 
on the species in  question30,31,33. Future studies specifically into the conservation of CGG STRs across species 
may shed light onto the biological role of these rare repeats.
Further highlighting the potential clinical relevance of CGG expansions, we saw a significant overrepre-
sentation of CGG-repeats in neurodevelopmental disease genes, with 410 of the 1295 genes of an in-house 
neurodevelopmental disease diagnostic panel being associated with a CGG repeat (p < 2.2e-16; Table 2). One of 
these genes, ARID1B, causes Coffin-Siris syndrome, an autosomal dominant form syndromic ID and  autism34. 
Strikingly, we observed 13 unique CGG-repeats associated with ARID1B, three immediately upstream of the 
gene, one in the 5′-UTR, eight exonic and one intronic (Fig. 5). Presence of multiple repeats within a single gene 
is a common feature, seen in 1097 genes. For ARID1B, all of the CGG-repeats were polymorphic in our cohort. 
Interestingly, repeat characteristics for ARID1B were in line with observations from repeats in known fragile 
sites, which show a median repeat length of 5–43, can range from 1 to 120 repeats and have polymorphism rate 
of 48% to 100% (Table 1). For example, the size of the largest exonic repeat ranged from 8–53 CGG repeats with 
a median size of 20 units and a polymorphism rate of 41%, and the adjacent repeat exhibited a maximum repeat 
length of 48 units and polymorphism rate of 97%.
Combining the association to known neurodevelopmental disease genes and the observed overall length vari-
ability of CGG-repeats with their predominant location in regulatory regions, the abundance of repeat-associated 
genes involved in transcription regulation, revealed by the GO-term analysis and the predicted haploinsufficiency 
of the associated genes, we hypothesize that many CGG-associated genes may be candidate genes for disease, e.g. 
NOVA alternative splicing regulator 2 (NOVA2) gene. We observed that within our cohort NOVA2 was associated 
with five unique polymorphic repeats, 4 of which are polymorphic in our control dataset (Fig. 5). The largest 
repeat fell within the 5′-UTR, displayed a median repeat length of 36 units and an 87% polymorphism rate. It 
also displayed one of the larger repeat lengths observed within our cohort, with a length of 56 units. In line with 
our suspicion, the Developmental Disorders Genotype–Phenotype Database (DDG2P) has flagged NOVA2 as 
being a probable cause of ID as a consequence of a loss of function event. Future analysis needs to determine 
whether repeat expansions in these genes occur and contribute to disease.
We observed a “soft-limit” to the length of observed CGG STRs at approximately 50 CGG units (Fig. 4). This 
may be due to both the biological nature of CGG STRs and/or a technical limitation of ExpansionHunter. As 
pathogenic effects may manifest in an individual when a CGG extends into the pre-mutation range, this may 
be why CGG repeats beyond 50 units are rare. However, this phenomenon would require confirmation through 
further investigations. The likely reason for the observation of the CGG STR soft-limit is that ExpansionHunter 
relies on the presence of fully in-read repeats to estimate when STR size has extended beyond read length. 
Therefore, if a trinucleotide repeat has extended beyond read length (150 bp), but no full in-read repeats are 
present, then the algorithm could estimate the repeat length at a maximum of 50 units. It would only be when a 
repeat has extended considerably past read-length that multiple in-read repeats would be consistently detected 
and that ExpansionHunter could report a repeat length beyond 50.
Interestingly, a recent report observed premutation-ranged CGG-repeat expansions in the LOC642361/
NUTM2B-AS1, LRP12, and NBPF9 genes. The associated disorders share a striking clinical similarity to 
 FXTAS35–39. The similarities between the clinical manifestations of these disorders add further evidence to the 
theory that the pathological characteristics of expanded CGG-repeats are being replicated elsewhere in the 
genome, independent of the associated gene. The replication of STRs elsewhere in the genome resulting in similar 
pathogenic characteristics has been observed in other repeat expansion disorders. For example, familial adult 
myoclonic epilepsy which is caused by an expanded TTTTA/TTTCA repeat has been detected at multiple loca-
tions throughout the  genome40. Our study predicts that premutation sized CGG-repeats may be considerably 
more common than currently considered. Given the relatively low yield of screening studies for FMR1-associated 
CGG-repeats in the premutation range in clinically relevant patient populations, it could be recommended to 
rescreen these same populations for all repeats in our CGG-catalogue for potential disease-causing expansions.
While our work was under review, a study conducted by Trost et al.41 was published that investigated STRs of 
2–20 bp in a genome-wide setting and in relation to autism spectrum  disorder41. In our study, we detected a much 
higher number of CGG STR loci than Trost and colleagues, as the emphasis of their work was on expanded STR 
loci utilizing ExpansionHunter  Denovo42. This algorithm only detects repeat expansions that exceed the length 
of the sequencing reads, typically 150 bp, corresponding to 50 CGG repeat expansions. Similarly, to Trost and 
colleagues, we also detected CGG repeats displaying considerable size and polymorphisms at all cytogenetically 
visible folate-sensitive fragile sites. These repeats are prime candidates for the causative element of these fragile 
sites and are previously unreported before these studies.
In conclusion, we characterized 6101 CGG-repeats in the human genome, of which over 90% are polymor-
phic in our reference set of 454 individuals, a percentage that is likely to rise should additional populations be 
screened. A potential limitation of this study is the reliance on a reference genome to construct the baseline STR 
 panel43. We demonstrated that many repeats could contract to less than 4 repeat units of length. Therefore, any 
repeat loci contracted, deleted, or misaligned in the samples used to construct the reference genome would be 
missed in the analyses similar to our study. Although one would expect that these repeats form a minority in our 
analysis, it would be interesting to evaluate future and more accurate high quality de novo genome assemblies 
for the presence of additional CGG repeats.
About two-thirds of the CGG-repeats are at or in the vicinity of gene promoters, including hundreds of genes 
known to be associated with a neurodevelopmental disease. Additional genes include many candidate genes for 
neurodevelopmental disease on the basis of gene-ontology analysis and haploinsufficiency prediction scores. 
Our study in a control population has not revealed expansions into a potentially pathogenic range, but repeats 
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Figure 5.  Repeat distribution and repeat length variation in several genes across the control population. All 
CGG STRs observed in these three genes were polymorphic. (a) ARID1B contained 13 CGG STRs. 3 upstream, 
1 5′-UTR, 8 exonic, and 1 intronic; (b) NOVA2 contained 5 CGG STRs. 1 upstream, 1 5′-UTR, and 3 exonic; 
and (c) SKI contained 15 CGG STRs. 4 upstream, 1 exonic and 10 intronic.
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within the premutation range were observed, and hundreds of CGG-repeats demonstrated characteristics similar 
to those observed in repeats associated to fragile sites, that have been proven to expand. Additionally, we gained 
insight into the unexpected behaviour of CGG-repeats with lower median repeat sizes, where we noticed expan-
sions nearing the premutation range. Furthermore, as the pathological mechanism of the CGG-repeat in neu-
rodegenerative disorders such as FXTAS is not well understood, our study raises questions about the biological 
role of CGG-repeats in general, and about the risk, they may pose with regard to evolution and genetic disease.
Methods
Genome‑wide tandem repeat panel construction. The genomic location of all short tandem repeats 
of 4 units and higher present in the GRCh37/hg19 human reference genome assembly was derived by applying 
the Tandem Repeats Finder algorithm (version 4.09) to a FASTA file of the hg19  genome44. The parameters used 
were MatchScore: 2, MismatchScore: 5, IndelScore: 17, MaxPeriod: 20, PM: 80, PI: 10, MinScore: 24, and Max-
Length: 1000. The resulting panel was then filtered for all reading frame variants of CGG-repeats (GCC, CCG, 
GGC, CGC, GCG). The resulting repeat panel was then filtered further utilizing pairwise2 from the BioPython 
(version 1.75) library to conduct local pairwise alignments to determine the longest repeats with least interrup-
tions within the reference genome regions identified through Tandem Repeats Finder. The parameters used for 
pairwise2 were x: 1/2, m: − 2, d: − 5, and c: − 1. The resulting repeat panel consisted of 6110 distinct CGG-repeat 
loci.
Whole genome sequencing. PCR whole-genome sequencing (WGS) of 100 individuals with no known 
repeat disorders or repeat expansions were included in this study. WGS was conducted by BGI (Shenzhen, 
Guangdong, China) as previously  described45. All clean reads were aligned to the GRCh37/hg19 reference 
genome using the Burrows-Wheeler Aligner (BWA v0.7.12). Picard-tools (v1.118) was used to sort the align-
ments by coordinate and subsequently convert and store the genome alignment as BAM files.
PCR-free WGS was conducted on DNA samples obtained from blood of 544 non-affected individuals from 
the NGC  cohort22. DNA samples were shipped to Illumina (UK) for sequencing and were prepared with the 
Illumina TruSeq DNA PCR-Free Sample preparation kit (Illumina, Inc) as previously  described22,46. Samples 
were sequenced on the Illumina Hiseq 2500, and quality control and read alignment to the human reference 
genome GRCh37/hg19 was performed by Illumina as previously  described22,47. Average coverage obtained was 
30–40 × for the nuclear genome and 800–1000 × for the mitochondrial genome.
Genome‑wide STR analysis utilizing GangSTR and ExpansionHunter. Two separate short tan-
dem repeat genotyping algorithms were utilized, namely GangSTR (version 2.0) and ExpansionHunter (version 
3.1.2), developed by Mousavi et al.20 and Dolzhenko et al.21 respectively. For both ExpansionHunter and Gang-
STR, the default parameters were used, and the same hg19 FASTA file was used for the genome reference argu-
ments. For the GangSTR “–regions” and the ExpansionHunter “–variant-catalog” arguments, custom BED and 
JSON files were generated respectively, based on the CGG repeat panel constructed by Tandem Repeats Finder, 
as described in the above section. The VCF output files of both algorithms were then parsed to extract the STR 
data using the PyVCF (version 0.6.8) library in a Python 3.6.8 environment. ExpansionHunter and GangSTR 
were applied to the 100 control WGS samples, sequenced by BGI, for comparison of genotyper accuracy. Expan-
sionHunter was applied to 544 control WGS samples, sequenced by Illumina, to obtain the repeat characteristics 
reported in this study. An R (version 3.6.3) environment was used for downstream data analysis of the STR data. 
Data was analysed and summarised by repeat locus, chromosome, and sample. A repeat at a given locus was 
defined as polymorphic if at least one individual displayed a repeat length which differed from the median repeat 
length, at that given locus, of the screened population. The polymorphism rate of a repeat locus was defined as 
the proportion of alleles which displayed a polymorphic repeat length throughout the screened cohort.
Gene annotation. Gene-based annotation of the detected CGG short tandem repeat (CGG-STR) loci was 
carried out using the software tool ANNOVAR and the refGene hg19 gene  database48. If a repeat fell outside of 
the gene body, it was annotated as being “upstream” or “downstream” if they were located within 1 kb of the start 
of the 5′-UTR or the end of the 3′-UTR of the gene in question. If a repeat was located over 1 kb from a gene, it 
was defined as “intergenic”. Haploinsufficiency and pLI score data per gene was obtained from the DECIPHER 
Table 2.  Results of Chi-squared tests for 410 ID-associated genes that contained one or more CGG STR which 
were present in a list of 1295 genes used for clinical screening of ID. *The total number of genes is equal to 
410, however as some genes contained multiple repeats within different regions some genes are represented in 
multiple region subsets.
Repeat location Number of Genes X2 p value
5′-UTR 241 240.44 1.244e−6
3′-UTR 7 23.507  < 2.2e−16
Upstream 138 107.89  < 2.2e−16
Intronic 164 178.28  < 2.2e−16
Exonic 184 152.42  < 2.2e−16
Total* 410 264.05  < 2.2e−16
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and ExAC databases  respectively46,49. The PANTHER Classification System (v14.1) (Gene Ontology Phyloge-
netic Annotation Project) was used to facilitate a high-throughput gene ontology analysis of the genes identified 
by our STR analysis and gather functional and molecular characterization data of the genes associated with 
CGG-repeats.
Repeat length validation by Sanger sequencing. Six genes within the folate-sensitive fragile site 
regions were selected for validation of the predicted ExpansionHunter repeat lengths. PCR amplification and 
Sanger sequencing were used to validate called repeats lengths in 8 individuals from our control cohort. PCR 
reactions were prepared using GoTaq polymerase and reagents (Promega, Leiden, Netherlands). PCR reactions 
were run on a Veriti 96 Well Thermal Cycler (Applied Biosystems, Foster City, CA, USA). PCR products were 
sequenced by use of an ABI Prism 3130 Genetic Analyzer (Applied Biosystems, Foster City, CA, USA). The DNA 
primers were supplied by Integrated DNA Technologies, Leuven, Belgium.
Data availability
Most data generated or analysed during this study are included in this published article or in the supplementary 
information files. The other datasets used and/or analysed during the current study are available from the cor-
responding author on reasonable request.
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